UNSPSC 51102856: Hydrocortisone/neomycin/polymyxin b

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE250. This VA Drug Class (DE250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL.

UNSPSC 51102856 Hydrocortisone/neomycin/polymyxin b is a Commodity code that in practice captures pharmaceutical and medical supply procurement across state and local government, though recent activity under this specific code does not show direct alignment with the hydrocortisone/neomycin/polymyxin b formulation itself. The four most recent opportunities tagged to this code span naloxone procurement, direct-to-manufacturer prescription program capability assessment, fire rescue medical and first aid supplies, and multi-source generic pharmaceuticals and OTC products distributed through cooperative purchasing. The issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and state-led cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). The scope of work reflects broader pharmaceutical and medical supply management rather than the specific topical antiseptic formulation named in the code — state and local governments are sourcing emergency response medications, establishing direct manufacturer relationships to optimize pharmacy benefit costs, stocking rescue equipment and consumables, and aggregating generic drug procurement across multiple jurisdictions.

Geographic activity concentrates in Florida, Texas, Minnesota, and Oregon, with the Minnesota cooperative purchasing vehicle serving multi-state membership. Representative recent solicitations include Seminole County's IFB 60459723LAS (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to Sanford, Florida; the City of Tampa's IFB 26P00145 (due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, designated as a Small Local Business Enterprise sheltered market opportunity with an estimated contract value of $700,000; Texas HHS Commission's RFI HHS0017013 (due April 3, 2026) seeking vendor capability information on direct-to-manufacturer prescription fulfillment; and the Minnesota Department of Administration's RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with awards effective July 1, 2026. The disparity between the code's nominal scope and the recent opportunities suggests this Commodity code may be applied inconsistently across jurisdictions or may be a catch-all category for pharmaceutical and medical supply activity not captured by more specific codes.